2014


To access this material please log in or register

Register Authorize
2014/№5

Safety of coronary bypass surgery during ongoing aspirin treatment

Altarev S. S., Krivoshapova K. E., Malyshenko E. S., Plotnikov G. P., Ivanov S. V., Barbarash O. L.
Federal State Budgetary Institution “Research Institute for Complex Issues of Cardiovascular Diseases” at the Siberian Branch of the Russian Academy of Medical Sciences, Sosnovy Bulvar 6, Kemerovo 650002

Keywords: aspirin, coronary heart disease, coronary bypass surgery, surgical therapy


DOI: 10.18087/rhj.2014.5.1977

Background. Current guidelines recommend no need to discontinue aspirin before most elective surgeries. Nevertheless, the tactics of perioperative aspirin treatment varies at different medical institutions. A common practice is discontinuing aspirin before an elective surgery on the heart and large blood vessels for concerns about the increased risk of bleeding. Aim. To evaluate safety of coronary bypass (CB) surgery without preoperative aspiring withdrawal. Materials and methods. We analyzed data of patients who have had CB without preoperative aspirin withdrawal (aspirin treatment group) for the period from August through December, 2013 (103 patients). Reference group consisted of 223 patients who have had CB surgery after a standard preoperative preparation (standard treatment group). This standard preparation implied discontinuation of aspirin at least 5 days prior to the planned intervention and subcutaneous administration of direct anticoagulants (unfractionated or low molecular weight heparins) or the complete absence of antithrombotic therapy in the preoperative period (by judgment of doctor in charge). Results. Matching by propensity scores provided 74 pairs of patients. The study groups were comparable by most of clinical and medial history characteristics. Intra-operative loss of blood was comparable in the study groups (p=0.62); however drainage volumes were significantly larger in the aspirin treatment group during the first 6 and 12 hours postsurgery (mean difference, 35.3 ml; 95 % CI, 6.7 to 63.9 ml; p=0.001 and 66.2 ml; 95 % CI, 19.7 to 112.7 ml; p<0.001, respectively). Nevertheless, the total loss of blood for 24 h postsurgery was not significantly different between the study groups (mean difference, 63.9 ml; 95 % CI, – 0.7 to 128.5 ml; p=0.13). Cerebo- and cardiovascular events were not observed in any of the groups during the early postoperative period of CB. Incidence of resternotomy for bleeding was comparable in both groups. Conclusion. The results of study support the comparable safety of CB surgery with ongoing aspirin treatment or aspirin withdrawal at least 5 days prior to the surgery.
  1. Fihn SD, Gardin JM, Abrams J et al. 2012 ACCF / AHA / ACP / AATS / PCNA / SCAI / STS Guideline for the diagnosis and mana­gement of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol. 2012;60 (24):e44–e164.
  2. Verstraete M, Brown BG, Chesebro JH et al. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Eur Heart J. 1986 Jan;7 (1):4–13.
  3. Devereaux PJ, Mrkobrada M, Sessler DI et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med. 2014 Apr 17;370 (16):1494–503.
  4. Kamran M, Ahmed A, Dar MI, Khan AB. Effect of aspirin on postoperative bleeding in coronary artery bypass grafting. Ann Thorac Cardiovasc Surg. 2008 Aug;14 (4):224–9.
  5. Ferraris VA, Ferraris SP, Lough FC, Berry WR. Preoperative aspirin ingestion increases operative blood loss after coronary artery bypass grafting. Ann Thorac Surg. 1988 Jan;45 (1):71–4.
  6. Kallis P, Tooze JA, Talbot S et al. Preoperative aspirin decreases platelet aggregation and increases postoperative blood loss: a prospective, randomised, placebo controlled, double-blind clinical trial in 100 patients with chronic stable angina. Eur J Cardiothorac Surg. 1994;8 (8):404–9.
  7. Herwaldt LA, Swartzendruber SK, Edmond MB et al. The epidemiology of hemorrhage related to cardiothoracic operations. Infect Control Hosp Epidemiol. 1998 Jan;19 (1):9–16.
  8. Austin PC. A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003. Stat Med. 2008 May 30;27 (12):2037–49.
  9. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrica. 1983;70 (1):41–55.
  10. Stuar EA. Matching methods for causal inference: a review and a look forward. Stat. Sci. 2010;25 (1):1–21.
  11. Jacob M, Smedira N, Blackstone E et al. Effect of timing of chronic preoperative aspirin discontinuation on morbidity and mortality in coronary artery bypass surgery. Circulation. 2011 Feb 15;123 (6):577–83.
  12. Sun JC, Whitlock R, Cheng J et al. The effect of pre-operative aspirin on bleeding, transfusion, myocardial infarction, and mortality in coronary artery bypass surgery: a systematic review of randomized and observational studies. Eur Heart J. 2008;29 (8):1057–1071.
  13. Bélisle S, Hardy JF. Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. Ann Thorac Surg. 1996 Dec;62 (6):1908–17.
  14. Alghamdi AA, Moussa F, Fremes SE. Does the use of preoperative aspirin increase the risk of bleeding in patients undergoing coronary artery bypass grafting surgery? Systematic review and meta-analysis. J Card Surg. 2007 May-Jun;22 (3):247–56.
  15. Myles PS, Smith J, Knight J et al. Aspirin and Tranexamic Acid for Coronary Artery Surgery (ATACAS) Trial: rationale and design. Am Heart J. 2008 Feb;155 (2):224–30.
Altarev S. S., Krivoshapova K. E., Malyshenko E. S. et al. Safety of coronary bypass surgery during ongoing aspirin treatment. Russian Heart Journal. 2014;79 (5):278–286

To access this material please log in or register

Register Authorize
Ru En